🇺🇸 FDA
Pipeline program

Zushima plaster with high dose

81758

Approved small_molecule completed

Quick answer

Zushima plaster with high dose for Osteoarthritis is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Osteoarthritis
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials